These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 13851489)

  • 21. [On the adrenergic action of iproniazid, inhibitor of monoamine oxidase].
    MEYER F
    C R Hebd Seances Acad Sci; 1961 Apr; 252():2616-8. PubMed ID: 13769974
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of sympathomimetic drugs in eliciting hypertensive responses to reserpine in the rat, after pretreatment with monoamineoxidase inhibitors.
    Cashin CH
    Br J Pharmacol; 1972 Feb; 44(2):203-9. PubMed ID: 4668590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reserpine rigidity and adrenergic neurones.
    Morrison AB; Webster RA
    Neuropharmacology; 1973 Aug; 12(8):725-33. PubMed ID: 4795744
    [No Abstract]   [Full Text] [Related]  

  • 24. Some pharmacological observations on tranylcypromine (SKF trans-385), a potent inhibitor of monoamine oxidase.
    TEDESCHI RE; TEDESCHI DH; AMES PL; COOK L; MATTIS PA; FELLOWS EJ
    Proc Soc Exp Biol Med; 1959 Nov; 102():380-1. PubMed ID: 13837261
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of diamine oxidase in vivo by hydrazine derivatives.
    BURKARD WP; GEY KF; PLETSCHER A
    Biochem Pharmacol; 1960 Jul; 3():249-55. PubMed ID: 13806127
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine.
    HESS SM; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1959 Nov; 127():178-81. PubMed ID: 14401504
    [No Abstract]   [Full Text] [Related]  

  • 27. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo.
    MAXWELL DR; GRAY WR; TAYLOR EM
    Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Submicroscopic catecholamine stores as sites of attack of the psychopharmaca, reserpine and monoamine oxidase inhibitors].
    Hassler R; Bak IJ
    Nervenarzt; 1966 Nov; 37(11):493-8. PubMed ID: 5983176
    [No Abstract]   [Full Text] [Related]  

  • 29. CHEESE AND MONOAMINE OXIDASE INHIBITORS. INTERACTION IN ANAESTHETISED CATS.
    NATOFF IL
    Lancet; 1964 Mar; 1(7332):532-3. PubMed ID: 14100189
    [No Abstract]   [Full Text] [Related]  

  • 30. [ON THE MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS].
    HORNYKIEWICZ O
    Wien Klin Wochenschr; 1964 Apr; 76():289-93. PubMed ID: 14223504
    [No Abstract]   [Full Text] [Related]  

  • 31. Neurophysiological studies with monoamine oxidase inhibitors.
    SCHALLEK W
    Dis Nerv Syst; 1960 Mar; 21(3)Suppl():64-6. PubMed ID: 14442400
    [No Abstract]   [Full Text] [Related]  

  • 32. FUNCTION OF N-ACETYL ASPARTIC ACID IN THE BRAIN: EFFECTS OF CERTAIN DRUGS.
    MCINTOSH JC; COOPER JR
    Nature; 1964 Aug; 203():658. PubMed ID: 14250993
    [No Abstract]   [Full Text] [Related]  

  • 33. [ALPHA-METHYLDOPA DOES NOT INHIBIT THE SYNTHESIS AND STORAGE OF CATECHOLAMINES IN THE ADRENALS OF RAT].
    CLEMENTI F; FRESIA P; MORTARI A; SIOLI G
    Arch Int Pharmacodyn Ther; 1964 Nov; 152():179-87. PubMed ID: 14248344
    [No Abstract]   [Full Text] [Related]  

  • 34. EXCITATORY (ANTIDEPRESSANT?) EFFECTS OF MONOAMINE OXIDASE INHIBITORS ON THE REWARD SYSTEM OF THE BRAIN.
    POSCHEL BP; NINTEMAN FW
    Life Sci (1962); 1964 Aug; 3():903-10. PubMed ID: 14201701
    [No Abstract]   [Full Text] [Related]  

  • 35. FUNCTION AND METABOLISM OF CATECHOLAMINES IN THE BRAIN.
    MATSUOKA M
    Jpn J Pharmacol; 1964 Jun; 14():181-93. PubMed ID: 14215546
    [No Abstract]   [Full Text] [Related]  

  • 36. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
    HORITA A
    Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparative trial of four monoamine oxidase inhibitors on chronic depressives.
    BATES TJ; DOUGLAS AD
    J Ment Sci; 1961 May; 107():538-46. PubMed ID: 13687739
    [No Abstract]   [Full Text] [Related]  

  • 38. [INHIBITION OF RAT BRAIN MONOAMINE OXIDASES BY BETA-PHENYLISOPROPYLHYDRAZINE AND HARMALINE: HISTOCHEMICAL STUDY OF THE ACTION OF THESE INHIBITORS AND THEIR ANTAGONISM].
    BOUCHAUD C; COUTEAUX R; GAUTRON J
    C R Hebd Seances Acad Sci; 1965 Jan; 260():348-51. PubMed ID: 14305447
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of monoamine oxidase in the cardiac accumulation of norepinephrine.
    Lee WC; Yoo CS
    Arch Int Pharmacodyn Ther; 1967 Sep; 169(1):221-36. PubMed ID: 6055131
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.